A new study by Canadian researchers has found that two in five people are resistant to the effect of the cholesterol-lowering drugs.
While statins are considered to be the best bet to reduce the levels of low-density lipoprotein (LDL), or bad cholesterol, a new study by Canadian researchers has found that two in five people are resistant to the effect of the drugs. According to the study presented at the Canadian Cardiovascular Congress, over 40 percent of people who take statins have a protein called as resistin which not only increased the production of LDL but also inhibited the effects of statins.
“The bigger implication of our results is that high blood resistin levels may be the cause of the inability of statins to lower patients’ LDL cholesterol levels”, lead researcher Dr Dr Shirya Rashid, from McMaster University, said.
Source-Medindia